INTELLIGENCE: AMICUS THERAPUTICS JUMPS 23%, SEVEN POTENTIAL BIOTECH BUYOUT TARGETS $FOLD $BMRN $EXEL $INCY $MDVN $RARE $SGEN $TSRO

This post was just published on ZYX Buy Change Alert. FOLD plans to submit a new drug application to FDA for the oral precision medicine migalastat for Fabry disease.  The stock is jumping on the news. We are not ...
Read more »

INTELLIGENCE: SEVEN POTENTIAL BIOTECH BUYOUT TARGETS IN WAKE OF ARIAD BUYOUT $ARIA $BMRN $EXEL $FOLD $INCY $MDVN $RARE $SGEN $TSRO

This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

INTELLIGENCE: EIGHT POTENTIAL BUYOUT TARGETS IN THE WAKE OF MEDIVATION BUYOUT $ARIA $BMRN $EXEL $FOLD $INCY $RARE $SGEN $TSRO $MDVN $PFE

This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria ...
Read more »

THE ARORA REPORT SUBSCRIBERS MAKE 143% ANNUALIZED RETURN ON MEDIVATION BUYOUT BY PFIZER $MDVN $PFE

This post was just published on ZYX Buy Change Alert. MDVN is the 113th company in our portfolio involved in M&A.  The Arora Report's unrivaled performance in picking companies that get bought out continues. Congratulations to those holding MDVN.  ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

Follow

Get every new post delivered to your Inbox

Join other followers